M. Hümpel

1.4k total citations
53 papers, 1.1k citations indexed

About

M. Hümpel is a scholar working on Pharmacology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, M. Hümpel has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 13 papers in Public Health, Environmental and Occupational Health and 10 papers in Oncology. Recurrent topics in M. Hümpel's work include Reproductive Health and Contraception (12 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Drug Transport and Resistance Mechanisms (9 papers). M. Hümpel is often cited by papers focused on Reproductive Health and Contraception (12 papers), Pharmacogenetics and Drug Metabolism (9 papers) and Drug Transport and Resistance Mechanisms (9 papers). M. Hümpel collaborates with scholars based in Germany, United States and Italy. M. Hümpel's co-authors include H. Wendt, Ulrich Speck, Wolf‐Dieter Schleuning, Olaf Schaefer, B. Nieuweboer, Rolf Bohlmann, W. Kŕause, W. Kuhnz, Karl‐Heinrich Fritzemeier and B. Düsterberg and has published in prestigious journals such as Gastroenterology, Journal of Agricultural and Food Chemistry and American Journal of Obstetrics and Gynecology.

In The Last Decade

M. Hümpel

53 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Hümpel Germany 18 350 206 194 192 146 53 1.1k
Sheikh Abdul Saeed Pakistan 17 247 0.7× 261 1.3× 148 0.8× 59 0.3× 95 0.7× 43 1.1k
Anjali Rao India 20 144 0.4× 421 2.0× 193 1.0× 113 0.6× 44 0.3× 72 1.8k
George Falkay Hungary 20 87 0.2× 372 1.8× 74 0.4× 106 0.6× 120 0.8× 56 1.2k
Jeffrey S. Bland United States 22 241 0.7× 393 1.9× 155 0.8× 119 0.6× 64 0.4× 55 1.2k
Mohammad Reza Panjehshahin Iran 19 130 0.4× 257 1.2× 70 0.4× 114 0.6× 34 0.2× 53 1.0k
Fengxiang Yan China 12 257 0.7× 331 1.6× 33 0.2× 110 0.6× 113 0.8× 25 935
Rieko Nakata Japan 23 146 0.4× 514 2.5× 97 0.5× 130 0.7× 34 0.2× 63 1.5k
Martha R. Harkey United States 18 489 1.4× 421 2.0× 212 1.1× 97 0.5× 72 0.5× 26 1.8k
Abdullah M. Al‐Bekairi Saudi Arabia 22 440 1.3× 263 1.3× 71 0.4× 51 0.3× 53 0.4× 54 1.9k
Frederick W. Stratman United States 19 97 0.3× 423 2.1× 89 0.5× 103 0.5× 74 0.5× 47 1.3k

Countries citing papers authored by M. Hümpel

Since Specialization
Citations

This map shows the geographic impact of M. Hümpel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Hümpel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Hümpel more than expected).

Fields of papers citing papers by M. Hümpel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Hümpel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Hümpel. The network helps show where M. Hümpel may publish in the future.

Co-authorship network of co-authors of M. Hümpel

This figure shows the co-authorship network connecting the top 25 collaborators of M. Hümpel. A scholar is included among the top collaborators of M. Hümpel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Hümpel. M. Hümpel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kutzsche, Janine, Christian Zafiu, Steffen Halbgebauer, et al.. (2023). Oral treatment with the all-d-peptide RD2 enhances cognition in aged beagle dogs – A model of sporadic Alzheimer’s disease. Heliyon. 9(8). e18443–e18443. 3 indexed citations
2.
Rad, Mohammad Navid Soltani, M. Hümpel, Olaf Schaefer, et al.. (2006). Pharmacokinetics and systemic endocrine effects of the phyto‐oestrogen 8‐prenylnaringenin after single oral doses to postmenopausal women. British Journal of Clinical Pharmacology. 62(3). 288–296. 77 indexed citations
3.
Hümpel, M., Olaf Schaefer, Ulrike Kaufmann, et al.. (2005). Tissue specificity of 8-prenylnaringenin: Protection from ovariectomy induced bone loss with minimal trophic effects on the uterus. The Journal of Steroid Biochemistry and Molecular Biology. 97(3). 299–305. 53 indexed citations
4.
Pepper, Michael S., Susan Hazel, M. Hümpel, & Wolf‐Dieter Schleuning. (2003). 8‐prenylnaringenin, a novel phytoestrogen, inhibits angiogenesis in vitro and in vivo. Journal of Cellular Physiology. 199(1). 98–107. 54 indexed citations
5.
Schaefer, Olaf, M. Hümpel, Karl‐Heinrich Fritzemeier, Rolf Bohlmann, & Wolf‐Dieter Schleuning. (2003). 8-Prenyl naringenin is a potent ERα selective phytoestrogen present in hops and beer. The Journal of Steroid Biochemistry and Molecular Biology. 84(2-3). 359–360. 87 indexed citations
6.
Kuhnz, W., et al.. (1997). In vivo conversion of norethisterone and norethisterone acetate to ethinyl etradiol in postmenopausal women. Contraception. 56(6). 379–385. 66 indexed citations
7.
Kuhnz, W., et al.. (1996). Influence of repeated oral doses of ethinyloestradiol on the metabolic disposition of [ 13 C 2 ]-ethinyloestradiol in young women. European Journal of Clinical Pharmacology. 50(3). 231–235. 9 indexed citations
8.
Kuhnz, W., et al.. (1995). A single-dose and 3-month clinical—pharmacokinetic study with a new combination oral contraceptive. Advances in Contraception. 11(3). 207–225. 8 indexed citations
11.
Hümpel, M., et al.. (1992). Pharmacokinetics, hydrolysis and aromatisation of norethisterone-3-oxime in female cynomolgus monkey. European Journal of Drug Metabolism and Pharmacokinetics. 17(4). 281–291. 7 indexed citations
12.
Hümpel, M., et al.. (1991). ZK 90 695: A new antiarthritic drug with tissue targeting properties. Inflammation Research. 32(1-2). 22–23. 1 indexed citations
13.
Li, Qigui, et al.. (1991). Investigations on the in vitro metabolism of five synthetic 19-norprogestins using hepatocyte suspensions isolated from five laboratory animal species. European Journal of Drug Metabolism and Pharmacokinetics. 16(2). 93–102. 2 indexed citations
14.
Hildebrand, Michael S., et al.. (1990). Plasma levels and urinary excretion of lormetazepam in patients with liver cirrhosis and in healthy volunteers. European Journal of Drug Metabolism and Pharmacokinetics. 15(1). 19–26. 13 indexed citations
16.
Hadgraft, Jonathan, Stephanie Hill, M. Hümpel, et al.. (1990). Investigations on the Percutaneous Absorption of the Antidepressant Rolipram in Vitro and in Vivo. Pharmaceutical Research. 7(12). 1307–1312. 10 indexed citations
17.
18.
Kŕause, W. & M. Hümpel. (1988). Pharmacokinetics of proterguride in rat and cynomolgus monkey. Xenobiotica. 18(1). 41–48. 9 indexed citations
19.
Kŕause, W. & M. Hümpel. (1988). Pharmacokinetics of the dopamine partial agonist, terguride, in the rat and rhesus monkey. European Journal of Drug Metabolism and Pharmacokinetics. 13(3). 185–194. 5 indexed citations
20.
Kŕause, W., et al.. (1984). Biotransformation of the stable prostacyclin analogue, iloprost, in the rat.. Drug Metabolism and Disposition. 12(5). 645–651. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026